News Sentiment

BCRX sentiment intelligence

BioCryst Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 48 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 10.45 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+6.2% over one week, +20.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

BioCryst Appoints David W. Jenkins as Chief Scientific Officer

Market Reaction

Price moving ahead of tone

69/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction 6.2% Price confirming higher
Trend fit Trend active 20.1% over four weeks
Fair value 40.2% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 22
Neutral 22
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
Stock Titan 6
Investing.com 6
Sahm 3
simplywall.st 3
Moomoo 2
Quiver Quantitative 2
Simply Wall Street 2

Event Lens

What the news is about

Classified themes
Market update 33
Deals and strategy 4
Earnings 4
Analyst action 3
Regulatory and legal 2
Guidance 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-48 of 48